Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions

NCT: NCT06576128 · RECRUITING

NCT IDNCT06576128
StatusRECRUITING
Start Date2024-09-10
Completion2026-12-15

Brief Summary

Sensory innervation of the femoral region which is the entry point for endovascular cardiac interventions such as coronary angiography,cardiac catheterization and percutaneous coronary intervention is complex.It is thought that the ilioinguinal and iliohypogastric nerves contribute mostly.With transversus abdominis plane block(TAPB),it is planned to provide analgesia by creating a block in these nerve branches that contribute to the sensory innervation of the intervention area.In addition;it was aimed to investigate patient's and physician's satisfaction during the procedure.

Frequently Asked Questions

What is Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions?

Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions is a clinical trial registered under NCT06576128. Current status: RECRUITING.

What is the status of NCT06576128?

The current status of NCT06576128 (Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions) is: RECRUITING.

When did Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions start?

Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions started on 2024-09-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.